The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,101–1,200 of 1,810
Jagadeesan, G., Das, T. K., Mendoza, J. M., Alrousan, G., Blasco-Conesa, M. P., Thangaraj, P., & Ganesh, B. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073140 · Cited by 2
“However, these metabolic adaptations do not occur adequately in all pregnancies, leading to gestational diabetes mellitus [30,31].”
Ayyoubi, A., Mood, M. P., Hafezinori, H., et al. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100511 · Cited by 2
Tian, R., Xu, J., He, J., Chen, Z., Liu, Y., Chen, X., & Zou, Z. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01236-x · Cited by 3
Synergistic Potential of Berberine and Metformin: Unlocking Enhanced Anti‐Diabetic Efficacy
Bhushan, R., Rehman, M. T., Alajmi, M. F., Alam, M. R., Rahman, S., & Dubey, P. K. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70317 · Cited by 2
“Much controversy revolves around the diagnosis and control of gestational diabetes mellitus, making it a vital subject to define as the risk of maternal and fetal complications is raised in gestational diabetes mellitus (Plows et al. 2018).”
Tekin, S., Öçal, A., Güleroğlu, F. Y., Selcuk, C. G. O., Eyisoy, Ö. G., Ocal, E. U. B., & Çetin, A. (2025) · Journal of Perinatal Medicine · doi:10.1515/jpm-2025-0135 · Cited by 2
“The condition results from pancreatic β -cell dysfunction leading to insu ffi cient insulin production during pregnancy [3].”
Gestational Diabetes Melitus and Cord Blood Platelet Function Studied via the PFA-100 System
Mougiou, V., Boutsikou, Τ., Sokou, R., Kollia, M. E., Valsami, S. I., Pouliakis, A., Boutsikou, M., Politou, M., Iacovidou, N. M., & Iliodromiti, Z. (2022) · Diagnostics · doi:10.3390/diagnostics12071645 · Cited by 2
Predictive Factors of Successful Treatment of Gestational Diabetes with Metformin Monotherapy
Aboelfath, A. M. K., & el din, M. T. A. S. (2020) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2020.1080097 · Cited by 2
“Gestational diabetes mellitus (GDM) is diagnosed when a pregnant lady develops hyperglycemia without previous history of diabetes and it is considered as a serious pregnancy complication [1] [2].”
BackgroundN1-methylnicotinamide impairs gestational glucose tolerance in mice
Wei, X., Tan, Y., Huang, J., Dong, X., Feng, W., Liu, T., Yang, Z., Yang, G., & Luo, X. M. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0126 · Cited by 4
“During normal pregnancy, β-cells undergo hyperplasia in order to meet the metabolic demands of pregnancy, while during gestational diabetes, β-cells fail to compensate for the demands of pregnancy on a background chronic insulin resistance (Plows et al. 2018).”
Jing, L., Liang, Z., Liang, Y., Cao, X., Tang, X., Zhuang, H., Yin, X., Zhao, D., & Shen, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02451-0 · Cited by 3
Melekoğlu, R., Erenler, A. Ş., Kıran, T. R., İnceoğlu, F., & Uçkun, A. A. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70591 · Cited by 3
Alzaben, A. S., Bawazeer, N. M., Almoayad, F. A., Benajiba, N., Dodge, E., & Aboul-Enein, B. H. (2025) · Midwifery · doi:10.1016/j.midw.2025.104453 · Cited by 2
Fürst, A., Johnson, K. E., Nagel, E., Yerabandi, N., Kats, A. M., Gallagher, T. T., Gale, C. A., Palmsten, K. K., Pierce, S., Hoffman, S., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101235 · Cited by 5
“Although GDM typically resolves after delivery, it can have a lasting imprint on both parent [3] and offspring [3,4].”
Choi, H., Kim, N., Kim, N., & Ahn, Y.-S. (2024) · Toxics · doi:10.3390/toxics12120841 · Cited by 1
Maternal DNA methylation signatures of gestational diabetes across all stages of pregnancy
Srour, L., Bejaoui, Y., Jerobin, J., Dweik, M., Sankar, A., Qannan, A., Colak, N. A., Chagoury, O. L., Yousri, N. A., Farrell, T., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07237-0 · Cited by 2
“This shift is advantageous as it helps maintain higher glucose levels in the blood, ensuring enough glucose is available for the fetus by allowing it to be transported through the placenta [11].”
InfluentialTime to Move Beyond a Binary Criterion for Gestational Diabetes?
Musa, O. A. H., Syed, A., Khatib, M., Hamdan, A., Allah, A. H., Almahdi, H., Onitilo, A. A., Sheehan, M. T., Beer, S. F., Bashir, M., et al. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01514-x · Cited by 2
“The pathophysiology of GDM involves a combination of insulin resistance that worsens over pregnancy associated with pre-existing inadequacy in insulin secretion to overcome the worsening insulin resistance in pregnancy [10].”
Jamalpour, S., Phang, K. C., Vazifehmand, R., Kamyab, H., Omar, S. Z., & Zain, S. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-15459-x · Cited by 2
“impairment and peripheral tissue insulin resistance playing pivotal roles in its underlying pathophysiology 4 .”
Wadivkar, P., & Hawkins, M. A. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1338597 · Cited by 3
“In addition, reduced pancreatic b cell mass, reduced b cell number, b cell dysfunction, or a combination of all three factors (which can be either preexistent or directly related to pregnancy, depending on the individual) may contribute to insuf fi cient insulin secretion in pregnancy (3).”
BackgroundDiabetes mellitus and hypoglycemic disorders
Hashim, I. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822949-1.00017-6 · Cited by 3
Yang, N., Guo, R., Guo, Y., Wei, Y., & An, N. (2023) · Medicine · doi:10.1097/md.0000000000035498 · Cited by 2
“[3] The disorder may have no obvious clinical signs and symptoms in its early stages, but if left untreated, it can cause adverse pregnancy outcomes, including infection, polyhydram-nios, premature birth, macrosomia, and preterm labor, and may also lead to abnormal glucose metabolism in patients…”
BackgroundNew exploration on pathogenesis and early diagnosis of gestational diabetes
Bai, H. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i1.93826 · Cited by 3
Alastanos, J. N., Suri, D., DeLellis, H., & Mapugay, A. (2022) · Mental Health Clinician · doi:10.9740/mhc.2022.01.037 · Cited by 2
“In women who develop GDM, similar mechanisms may cause hyperglycemia including dysfunction of pancreatic beta-cells because of excessive insulin production as well as insulin resistance.(39) Pregnancy itself is an insulin resistant state, and additional risk factors for developing GDM include multiple pregnancies, inc…”
BackgroundInfluentialHussein-Aro, R., Maor‐Sagie, E., Toledano, Y., Hallak, M., & Gabbay‐Benziv, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111659 · Cited by 3
The association between maternal obesity and fetomaternal outcomes in twin pregnancies
Nagler, L., Eißmann, C., Wasenitz, M., Bahlmann, F., & Naimi, A. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306877 · Cited by 2
Zhao, L., Huang, Y., Wang, L., Ding, Z. W., Liu, J., Fan, T., Zhu, T., Lu, M., Gan, H., Gao, H., et al. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02237-7 · Cited by 2
“These differences likely stem from pathophysiological alterations unique to GDM, including chronic low-grade inflammation and insulin resistance [20], which may further impair triglyceride clearance, leading to more severe dyslipidemia.”
Gestational Diabetes Mellitus and Future Risk of Cardiovascular Disease
Bhake, R. C., Chittake, V., Lumpatki, S. B., Tiwari, S., & Unnikrishnan, A. G. (2025) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_12_25 · Cited by 3
Kocabaş, G. Ü., Şimşir, İ. Y., Yürekli, B. Ş., Karakulah, A. S., Durmaz, B., Koroglu, E. P., Yeral, S., Özcan, B., & Akdemir, A. (2023) · Obstetric Medicine · doi:10.1177/1753495x231216032 · Cited by 1
“While mid-upper arm circumference was not different between groups (27.75 [4] vs 29 [5] cm, p = 0.057) neck circumference was signi fi cantly higher in GDM group (33 [3] vs 34 [3] cm, p = 0.006).”
InfluentialKhandelwal, R., Nigam, A., & Chaubey, S. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1666_2025 · Cited by 1
Psychosocial, Behavioral, and Medical Drivers of Gestational Diabetes among Racial-Ethnic Groups
Gardner, A. B., Champion, M. L., Janevic, T., Yee, L. M., & Battarbee, A. N. (2025) · American Journal of Perinatology · doi:10.1055/a-2554-0925 · Cited by 1
Fayyazian, E., Khojasteh, F., Saeedinezhad, F., & Haghighi, M. (2021) · Medical - Surgical Nursing Journal · doi:10.5812/msnj.118769 · Cited by 1
Boko, W. D., Abera, R. G., Wolde, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3988939/v1 · Cited by 1
Yi, L., Wang, L., Sun, L., Zhang, N., Han, J., Wang, J., Song, S., Meng, X., Zhu, Y., & Wu, Q. (2026) · Journal of Ultrasound in Medicine · doi:10.1002/jum.70249 · Cited by 1
Karabay, G., Şeyhanlı, Z., Filiz, A. A., Çakır, B. T., Aktemur, G., Sucu, S., Tonyalı, N. V., Karabay, U., Çelen, Ş., & Yılmaz, Z. V. (2025) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1616423 · Cited by 1
Hossin, M. Z., Gadermann, A., Nagy, E., Gill, R., Gagné, M. H., Faxén, J., & Razaz, N. (2026) · PLoS Medicine · doi:10.1371/journal.pmed.1004890 · Cited by 1
Aycan, Ö., & Sevde, A. K. S. U. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-06257-5 · Cited by 1
“Despite a large body of evidence linking PGDM to more adverse pregnancy outcomes than GDM due to pre-pregnancy hyperglycemia and prolonged exposure to intrauterine hyperglycemia, conflicting results have also been reported [14–17].”
Association of plasma Omentin-1 and gestational diabetes mellitus in local population of Pakistan.
Nazar, S., Zufishan, S., Masood, S. H., et al. (2022) · The Professional Medical Journal · doi:10.29309/tpmj/2022.29.10.7108 · Cited by 1
Metabolic Dysfunction–Associated Steatotic Liver Disease in Pregnancy
Han, H., Marcus, P. S., & Fong, T. (2025) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001435 · Cited by 2
Zhang, S., & Dong, Y. (2026) · Nutrición Hospitalaria · doi:10.20960/nh.06183 · Cited by 1
Chieu, R. V., Hamilton, K., Ryan, P. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.14.557457 · Cited by 1
Eryptosis contributes to gestational diabetes mellitus in maternal obesity
Лазуренко, В. В., Zhelezniakov, O. Y., & Prokopіuk, V. (2024) · Inter Collegas · doi:10.35339/ic.11.3.lzp · Cited by 1
Srivastava, H., Mathe, P., Mondal, N., Srivastava, S., Madhu, S., & Agarwal, R. (2023) · Cureus · doi:10.7759/cureus.41858 · Cited by 4
“The main pathology for the development of GDM remains beta cell dysfunction along with chronic insulin resistance [4].”
BackgroundTaweerutchana, V., Choksakunwong, S., Lerwattrakarn, A., Chalermwai, W. V., Intralawan, T., & Lertwattanarak, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34239 · Cited by 1
“This surge potentially heightens insulin resistance [42], leading to increased blood glucose levels.”
BackgroundAdiponectin/leptin ratio - a marker of insulin sensitivity in pre-eclampsia and fetal growthPreprint
de Knegt, V. E., Hedley, P. L., Eltvedt, A. K., Placing, S., Wøjdemann, K. R., Shalmi, A. C., Rode, L., Kanters, J. K., Sundberg, K., Tabor, A., et al. (2022) · medRxiv · doi:10.1101/2022.10.13.22281056 · Cited by 1
GDM-Induced Vascular Injury and Its Relationship with Fetal Metabolic Impairment
Espinoza, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102626 · Cited by 3
Bianchi, C., Resi, V., Manicardi, E., Burlina, S., Sculli, M. A., Formoso, G., & Sciacca, L. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.03.008 · Cited by 1
Daraie, M., Rad, H. A., Amiri, F. N., Faramarzi, M., Gholinia, H., & Darzi, S. (2025) · Health Science Reports · doi:10.1002/hsr2.71292 · Cited by 1
“According to the latest International Diabetes Federation (IDF) estimate, GDM affects approximately 1% – 14% of pregnancies worldwide, representing approximately 18 million births per year [6].”
Ustick, J., Chakos, K., Jia, H., Hanneke, R., DiPiazza, B., Koenig, M. D., Ma, J., Man, B., Tussing-Humphreys, L. M., & Burton, T. C. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068829 · Cited by 1
Keser, M. K., & Yalçın, S. S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011352 · Cited by 2
Satkunanathan, P., Allard, C., Doyon, M., Perron, P., Bouchard, L., Hivert, M., & Peters, T. M. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07148-4 · Cited by 2
Integrating multi-omics and digital phenotyping for precision care in gestational diabetes
Xega, V., & Liu, J.-L. (2026) · Metabolism and Diseases · doi:10.1016/j.metdis.2026.100002 · Cited by 1
Readability Analysis of Online Health Information on Gestational Diabetes
Samuel, L., Fera, J., & Basch, C. H. (2023) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2023.2171240 · Cited by 2
“The sudden onset of chronic hyperglycemia during pregnancy has been attributed to dysfunctional glucose tolerance due to abnormalities in pancreatic beta-cells against a background of chronic insulin resistance (Plows et al. 2018).”
BackgroundQiu, H., Bao, Y., Huang, S., Zhong, Y., He, C., Tian, L., Zhang, Y., Luo, B., Liang, T., Pang, B., et al. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127736 · Cited by 1
Gestational Diabetes Mellitus in Asian Indian Population: Pathophysiology and Mechanism
Deepa, M., & Chandrasekaran, S. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-023-00367-8 · Cited by 3
Atalmış, H. A., Kulan, P., Tekin, S., Güler, E. Y., Güleroğlu, F. Y., Çim, N., & Çetin, A. (2025) · European journal of medical research · doi:10.1186/s40001-025-03584-2 · Cited by 1
“…of shared pathophysiology varies: hypertensive disorders involve inflammation [1, 8, 9], oxidative stress [10], and endothelial dysfunction [11], while gestational diabetes primarily involves metabolic dysregulation with inflammatory components that may be confounded by maternal obesity [12].”
Beneficial effects of non-herbal supplements on patients with diabetes
Lin, Y.-Y., Mattison, M. J., & Priefer, R. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102510 · Cited by 2
Exercise therapy for gestational diabetes mellitus: from basic to clinical
Niu, X., Wang, K., Li, L., & Zhang, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1716883 · Cited by 5
Vainder, M., Natt, N., Sayyar, P., Syeda, A., Ashraf, R., Mitsakakis, N., Feig, D. S., Kingdom, J. C., & D'Souza, R. D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217737 · Cited by 3
“…has well-established pathophysiological relevance in gestational diabetes mellitus (GDM) where it is often considered a failing fetoplacental unit due to the typically insulin resistant state of late pregnancy [22], it has also been observed in pregnant people with type 1 and type 2 diabetes.”
Khurshid, A., Parveen, Z., Jan, M. M., & Assad, M. (2022) · Archives of Medical Science - Civilization Diseases · doi:10.5114/amscd.2022.122272 · Cited by 1
Serum Betatrophin: What It Shows and How It Alters in Gestational Diabetes Mellitus
Melekoğlu, R., & Çelik, E. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_19 · Cited by 1
Zhou, F., Yin, B., Xi, Y., Zhang, J., & Bai, Y. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00889-0 · Cited by 1
“When mothers have hyper-glycemia, it causes fetal β-cell hyperplasia and boosts the endogenous production of insulin and insulin-like growth factor (IGF) 1 [33], which stimulate growth-promoting pathways in developing muscles, connective tissues, and adipose tissue [34].”
Lazarou, E., Panteli, T., Metallinou, D., Lambrinou, E., Kolokotroni, O., Miltiadous, P., & Hadjigeorgiou, E. (2025) · Midwifery · doi:10.1016/j.midw.2025.104513 · Cited by 3
Wang, L., Li, Y., Dai, C., Yuan, Y., Yuan, Q., & Li, J. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01870-2 · Cited by 1
“However, as pregnancy progresses, maternal levels of estradiol, progesterone, leptin, cortisol, human placental lactogen (hPL), and placental growth factor (PlGF) undergo significant changes, collectively leading to a 30–70% reduction in insulin sensitivity during mid-to-late pregnancy [7].”
Auckloo, S. B., & Banerjee, I. (2025) · Cureus · doi:10.7759/cureus.92270 · Cited by 2
“When the pancreas fails to keep up with the stress of insulin resistance, GDM develops [4,7].”
Prevalence of Gestational Diabetes Mellitus in Puerto Rico: A Study from 2016 to 2021
Delgado-Astacio, S., Tremblay, R. L., & Colón-Díaz, M. (2024) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2024.144017 · Cited by 1
Liao, C.-C., Lee, C.-I., & Li, J. (2025) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2025.10.178 · Cited by 1
A Review on Gestational Diabetes Mellitus: Present Concern
Kaur, N., Priyanka, K. Y., Kaur, P., & Chopra, M. (2021) · Environment Conservation Journal · doi:10.36953/ecj.2021.221215 · Cited by 1
“Leptin can be used as a biomarker as the level of leptin is higher in typical and overweight ladies with later GDM conclusion from the mid-second of gestation (Roca et al., 2012, Boyadzhieva et al., 2013).”
BackgroundPlacental DNA methylation changes in the development of gestational diabetes mellitusPreprint
Chen, F., Li, M., Fei, X., Zhu, W., Zhang, Z., Shen, Y., Mao, Y., Zhu, Q., Xu, J., Zhou, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1375478/v1 · Cited by 1
Factors influencing thrombelastography in pregnancy.
Cao, Y., Liang, T., Peng, J., et al. (2023) · PubMed · doi:10.11817/j.issn.1672-7347.2023.210530 · Cited by 1
Epigenetic Factors in Gestational Diabetes From Mother to Child: A Narrative ReviewPreprint
Araujo, C., Tieu, V., & Zeynalvand, G. (2023) · Preprints.org · doi:10.20944/preprints202307.1665.v1
Barghouti, M. J., Godoy, C., Farah, F., Ferreira, P. B., & Silva, J. C. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n2-053 · Cited by 4
Zinabu, E., Negash, M., Goshu, Y., Kebede, T., Kelem, A., & Tsegaye, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324163 · Cited by 1
Placental Malperfusion in Maternal Diseases
Nogueira, R. N., & Nogueira, F. S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1006689 · Cited by 1
İleri Glikasyon Son Ürünlerinin Gebelik Üzerine Etkisi
Özlem, A. K. I. N., & Özbek, Y. D. (2022) · Sakarya Üniversitesi Holistik Sağlık Dergisi · doi:10.54803/sauhsd.1000948 · Cited by 1
Predominant genetic mutations leading to or predisposing diabetes progress: A Review
Banoon, S. R., Alfathi, M. Y., Mostafavi, S. K. S., & Ghasemian, A. (2022) · Bionatura · doi:10.21931/rb/2022.07.04.66 · Cited by 1
“Pregnancy can reveal even mild deficiencies of insulin secretion, leading to glucose intolerance and gestational diabetes 13 .”
BackgroundLin, S., Wu, S., Liu, S., Huang, J., & Xie, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1854094 · Cited by 1
“The etiology of GDM is complex and not fully understood, but it is known to be associated with lifestyle factors such as diet and environmental exposures (7, 8), among which light exposure has been proposed as a potential risk factor (9).”
陈, 鹏. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14102784 · Cited by 1
Jiao, Y., Dai, Y., He, L., & Fei, Z. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s529756 · Cited by 1
Cumulative daily exposure to high temperature increases gestational diabetes risk
Granés, L., Cros, A. P., Espiell, A., Roel, E., Gallo, E., Basagaña, X., Ballester, J., Pistillo, A., & Duarte‐Salles, T. (2026) · Nature Health · doi:10.1038/s44360-026-00077-2 · Cited by 1
Antibodies against Clostridium butyricum in the children of mothers at risk for gestational diabetes
Peterson, C., Tagoma, A., Alnek, K., Bärenson, A., Vorobjova, T., Talja, I., Janson, H., Kirss, A., Kõljalg, S., Sinkkonen, A., et al. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2504021 · Cited by 1
“Microbiota dysbiosis at an early age is associated with various immune-mediated diseases and has been shown to promote allergy development [2,3,6,7].”
Cardiometabolic Diseases During Pregnancy and Their Impact on Long-Term Health
David, P. S., Takalkar, R., & Vegunta, S. (2025) · Journal of Women s Health · doi:10.1089/jwh.2025.0281 · Cited by 1
Хара, М. Р., Korda, I. V., Кулянда, О. О., & Podilska, T. I. (2025) · Neonatology surgery and perinatal medicine · doi:10.24061/2413-4260.xv.2.56.2025.26 · Cited by 1
Arshad, R., Amir, E., Pahore, A. K., et al. (2023) · Gynecology and Obstetrics Clinical Medicine · doi:10.1016/j.gocm.2023.05.003 · Cited by 1
Study on the Relationship between Hypothyroidism during Pregnancy and Gestational Diabetes Mellitus
李, 可. (2023) · Medical Diagnosis · doi:10.12677/md.2023.133042 · Cited by 1
Yakupoğlu, E., & Altuntaş, M. (2023) · Akdeniz Medical Journal · doi:10.53394/akd.1198449 · Cited by 1
Gestational diabetes mellitus: state of art
Pletneva, S. A., Enkova, E. V., Khoperskaya, O. V., Вячеславович, Ш. С., & Enkova, V. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-112 · Cited by 4
Serum Betatrophin: What It Shows and How It Alters in Gestational Diabetes Mellitus
Melekoğlu, R., & Çelik, E. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_19-1 · Cited by 1
Sex Differences in Atherosclerosis and its Clinical Complications
Reddy, T. K., Littman, E., Elder-Odame, P., Hussain, Z., & Michos, E. D. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01383-y · Cited by 1
“Women are also at an increased risk of developing T2D if they have had GDM. Gestational diabetes globally affects about 16.5% of pregnancies and occurs due to impaired glucose tolerance from dysfunctional pancreatic β-cells and chronic insulin resistance [ 20].”
InfluentialBartáková, V., Ambrožová, E., Žák, P., & Kaňková, K. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1778006 · Cited by 2
“…Studies further suggest the contribution of additional factors, including polycystic ovary syndrome, multigravidity, increased weight gain during pregnancy, higher glycaemic variability, a sedentary lifestyle, smoking and pre-existing hypertension (Plows et al., 2018; Ustianowski et al., 2023).”
Kağıtçı, M., Şentürk, Ş., Kivrak, M., Puşuroğlu, M., Delibaş, D. D., & YILMAZ, B. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00603-4 · Cited by 1
“Pregnancy is considered as a diabetogenic state caused by increased counter-regulatory hormones produced by the placenta, which mainly cause progressive insulin resistance [1].”
Overlap of Gestational Diabetes Mellitus and Pre-eclampsia: A Scoping Review
Lunghar, J., Pramodkumar, T. A., Deepa, M., Bhavadharini, B., Chaudhari, U. K., Sachdeva, G., Joshi, S., Sagili, H., Keepanasseril, A., Kamalanathan, S., et al. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01880-6 · Cited by 4
Miro1- a key player in β-cell function and mitochondrial dynamics under diabetes mellitus
Kavyashree, S., Harithpriya, K., & Ramkumar, K. M. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102039 · Cited by 2
Tang, N., He, Y., Karatela, S., Zhong, J., Zeng, X., Lu, Q., Zhao, F., & Cai, L. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03603-2 · Cited by 1
Clinical Updates in Gestational Diabetes Mellitus
Shah, S., Adil, A., Isaacs, D. M., & Inteso, C. (2021) · ADCES in Practice · doi:10.1177/2633559x211008180 · Cited by 4
Can Maternal Hypoglycemia During Oral Glucose Tolerance Test Predict Adverse Pregnancy Outcomes?
Bai, Y., Xi, Y., Yin, B., Wu, K., & Zhang, J. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.08.001 · Cited by 2
Optimized Fuzzy Stacked Ensemble Model-Based Diabetes Prediction in Pakistan
Riaz, A., Khan, N., & Riaz, S. (2025) · Journal of Agricultural Biological and Environmental Statistics · doi:10.1007/s13253-025-00688-4 · Cited by 1
Prediabetes before pregnancy: implications for risk stratification and research
Bhattacharya, S., Mohan, V., Nagendra, L., & Saravanan, P. (2026) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000964 · Cited by 1
Gestational Diabetes Mellitus and Its Association With Pregnancy Outcomes
Nekkanti, V., Kishore, G., & Laalasa, G. (2020) · American Journal of PharmTech Research · doi:10.46624/ajptr.2020.v10.i4.001 · Cited by 1
“International Journal of Gynecology & Obstetrics 2009 Apr 1;105(1):50-5.”
BackgroundAltahan, L., Twynstra, J., Seabrook, J. A., & Mottola, M. F. (2026) · Healthcare · doi:10.3390/healthcare14091149 · Cited by 2
“GDM arises when this adaptive beta cell compensation is inadequate for the degree of pregnancy-induced insulin resistance, resulting in hyperglycemia that is first identified during pregnancy [14].”
Impact of changes in gestational diabetes mellitus diagnostic criteria during the COVID-19 pandemic
Neville, J., Foley, K., Lacey, S., Tuthill, A., Kgosidialwa, O., O’Riordan, M., O’Halloran, F., & Costelloe, S. J. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-03926-3 · Cited by 1
“GDM risk factors include high body mass index (BMI), advanced maternal age, and a family history of diabetes [4] [5].”
SCREENING GESTATIONAL DIABETES MELLITUS WITH NF-kB POLYMORPHISM AND GLOBAL DNA METHYLATION I
Majhi, D. P. P., Dash, S., Padhy, D. M., et al. (2022) · doi:10.53555/jptcp.v29i03.2751 · Cited by 1
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.